AHA Conference 2024 — New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a history of myocardial infarction.

Dr Harriette Van Spall (McMaster University, CA) sits down with the principal investigator of the NUDGE-FLU trial, (NCT05542004) Dr Tor Biering-Sørensen, to discuss the latest insights and data.

NUDGE-FLU is a prospective, randomized, open-label implementation trial investigating the impact of electronic nudges on influenza vaccine uptake amongst eligible candidates. This research specifically investigated the outcomes of NUDGE-FLU in a cohort of patients with a history of myocardial infarction, exploring the effects of electronic, letter-based nudges as compared to usual care on influenza vaccine uptake by history of AMI. In the study, AMI was defined as an overnight hospitalization with ICD-10.

Findings showed that in a pooled analysis of 3 randomized trials with less than 2 million patients across a Danish population, electronic nudges emphasising the cardiovascular benefits of influenza vaccination improved uptake. This was particularly effective in patients with a history of AMI.

Recorded remotely from Hamilton, CA and Copenhagen, DK.

Editors: Jordan Rance and Yazmin Sadik.
Videographers: Mike Knight, Dan Brent, Oliver Miles, Tom Green, David Ben-Harosh.

Support: This is an independent interview produced by Radcliffe Cardiology.